144 related articles for article (PubMed ID: 35253645)
1. Points to consider to avoid unfair discrimination and the misuse of genetic information: A statement of the American College of Medical Genetics and Genomics (ACMG).
Seaver LH; Khushf G; King NMP; Matalon DR; Sanghavi K; Vatta M; Wees K;
Genet Med; 2022 Mar; 24(3):512-520. PubMed ID: 35253645
[No Abstract] [Full Text] [Related]
2. Stewardship of patient genomic data: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Best RG; Khushf G; Rabin-Havt SS; Clayton EW; Grebe TA; Hagenkord J; Topper S; Fivecoat J; Chen M; Grody WW;
Genet Med; 2022 Mar; 24(3):509-511. PubMed ID: 35253644
[No Abstract] [Full Text] [Related]
3. The interface of genomic information with the electronic health record: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Grebe TA; Khushf G; Chen M; Bailey D; Brenman LM; Williams MS; Seaver LH;
Genet Med; 2020 Sep; 22(9):1431-1436. PubMed ID: 32475985
[No Abstract] [Full Text] [Related]
4. Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; Chao E; Gannon JL; Greely HT; Hagman KDF; Mao R; Topper S;
Genet Med; 2020 Aug; 22(8):1285-1287. PubMed ID: 32404921
[No Abstract] [Full Text] [Related]
5. Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Chao EC; Astbury C; Deignan JL; Pronold M; Reddi HV; Weitzel JN;
Genet Med; 2021 Jul; 23(7):1179-1184. PubMed ID: 33864022
[No Abstract] [Full Text] [Related]
6. Points to consider in the practice of postmortem genetic testing: A statement of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; De Castro M; Horner VL; Johnston T; Macaya D; Maleszewski JJ; Reddi HV; Tayeh MK;
Genet Med; 2023 May; 25(5):100017. PubMed ID: 36799919
[No Abstract] [Full Text] [Related]
7. Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).
David KL; Best RG; Brenman LM; Bush L; Deignan JL; Flannery D; Hoffman JD; Holm I; Miller DT; O'Leary J; Pyeritz RE;
Genet Med; 2019 Apr; 21(4):769-771. PubMed ID: 30578420
[No Abstract] [Full Text] [Related]
8. DNA-based screening and population health: a points to consider statement for programs and sponsoring organizations from the American College of Medical Genetics and Genomics (ACMG).
Murray MF; Giovanni MA; Doyle DL; Harrison SM; Lyon E; Manickam K; Monaghan KG; Rasmussen SA; Scheuner MT; Palomaki GE; Watson MS;
Genet Med; 2021 Jun; 23(6):989-995. PubMed ID: 33727704
[No Abstract] [Full Text] [Related]
9. DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG).
Bean LJH; Scheuner MT; Murray MF; Biesecker LG; Green RC; Monaghan KG; Palomaki GE; Sharp RR; Trotter TL; Watson MS; Powell CM;
Genet Med; 2021 Jun; 23(6):979-988. PubMed ID: 33790423
[No Abstract] [Full Text] [Related]
10. Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG).
Li MM; Chao E; Esplin ED; Miller DT; Nathanson KL; Plon SE; Scheuner MT; Stewart DR;
Genet Med; 2020 Jul; 22(7):1142-1148. PubMed ID: 32321997
[No Abstract] [Full Text] [Related]
11. Clinical, technical, and environmental biases influencing equitable access to clinical genetics/genomics testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Matalon DR; Zepeda-Mendoza CJ; Aarabi M; Brown K; Fullerton SM; Kaur S; Quintero-Rivera F; Vatta M;
Genet Med; 2023 Jun; 25(6):100812. PubMed ID: 37058144
[No Abstract] [Full Text] [Related]
12. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
ACMG Board of Directors
Genet Med; 2019 Jul; 21(7):1467-1468. PubMed ID: 31019278
[No Abstract] [Full Text] [Related]
13. The designated record set for clinical genetic and genomic testing: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Tayeh MK; Chen M; Fullerton SM; Gonzales PR; Huang SJ; Massingham LJ; O'Daniel JM; Stewart DR; Stiles AR; Evans BJ;
Genet Med; 2023 Mar; 25(3):100342. PubMed ID: 36547466
[No Abstract] [Full Text] [Related]
14. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Chung WK; Gordon AS; Herman GE; Klein TE; Stewart DR; Amendola LM; Adelman K; Bale SJ; Gollob MH; Harrison SM; Hershberger RE; McKelvey K; Richards CS; Vlangos CN; Watson MS; Martin CL;
Genet Med; 2021 Aug; 23(8):1381-1390. PubMed ID: 34012068
[No Abstract] [Full Text] [Related]
15. Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG).
ACMG Board of Directors
Genet Med; 2021 Nov; 23(11):2027-2028. PubMed ID: 34183790
[No Abstract] [Full Text] [Related]
16. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic testing for uniparental disomy: a points to consider statement from the American College of Medical Genetics and Genomics (ACMG).
Del Gaudio D; Shinawi M; Astbury C; Tayeh MK; Deak KL; Raca G;
Genet Med; 2020 Jul; 22(7):1133-1141. PubMed ID: 32296163
[No Abstract] [Full Text] [Related]
18. ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
Genet Med; 2022 Jul; 24(7):1407-1414. PubMed ID: 35802134
[No Abstract] [Full Text] [Related]
19. Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG).
Deignan JL; Chung WK; Kearney HM; Monaghan KG; Rehder CW; Chao EC;
Genet Med; 2019 Jun; 21(6):1267-1270. PubMed ID: 31015575
[No Abstract] [Full Text] [Related]
20. Considerations for policymakers for improving health care through telegenetics: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Williams HE; Aiyar L; Dinulos MB; Flannery D; McClure ML; Lloyd-Puryear MA; Sanghavi K; Trotter TL; Viskochil D;
Genet Med; 2022 Nov; 24(11):2211-2219. PubMed ID: 36040445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
